Primary protein sequence alignment of engineered AcEZH2_ X, HsEZH2 (Q15910) and AcEZH2 (G1KPH4) 1 . Sequence alignment was performed using BLAST.
R)-5,8-dichloro-2-((4-ethyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)- 7-((1-(2-hydroxypropanoyl)piperidin-4-yl)oxy)-3,4-dihydroisoquinolin-1(2H)-one
Synthesis of intermediates
Compound 296g:
Oxalyl chloride (34 mL, 0.395 mol) was added to a solution of 3-methoxy-2-nitrobenzoic acid (60 g, 0.305 mol) in dry dichloromethane (600 mL), followed by N,N-dimethylformamide (0.6 mL, 7.8 mmol), which initiates mild gas evolution. The mixture was stirred at room temperature for two hours, then concentrated under vacuum to remove volatiles. The crude acid chloride was dissolved in dry dichloromethane (150 mL) then added dropwise to a cooled (5 °C) solution of aminoacetaldehyde diethylacetal (48 mL, 0.33 mol) and triethylamine (52 mL, 0.37 mol) in dry dichloromethane (250 mL).
The mixture was stirred at room temperature for two hours and then washed with saturated aqueous sodium bicarbonate (2 x 100 mL) and brine (100 mL N-chlorosuccinimide (20 g, 0.147 mol) was added to a solution of 8-amino-7-methoxy-3,4-dihydroisoquinolin-1(2H)-one (296c, 24 g, 0.125 mol) in N,N-dimethylformamide (250 mL) and stirred at room temperature overnight. The solution was partitioned between water (100 mL) and ethyl acetate (100 mL). The aqueous layer was further extracted with ethyl acetate (4 x 100 mL). The combined organic extracts were washed with brine (5 x 100 mL), dried over sodium sulfate, and concentrated to dryness. The residue was triturated with acetonitrile (200 mL), and the solids collected by filtration.
After drying, 8-amino-5-chloro-7-methoxy-3,4-dihydroisoquinolin-1(2H)-one (296d, 12.5 g, 44% yield) was obtained as a blue solid. A mixture of 4-ethyl-6-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (Cpd AA, 1.1 g, 6.8 mmol), (chloromethyl)benzene (1.1 mL, 9.4 mmol) and silver(I) oxide (1.8 g, 7.7 mmol) in anhydrous toluene (23 mL) was heated at 110 °C for 17 hours. The reaction mixture was cooled to 23 °C then filtered through CELITE®. The filtrate was concentrated under vacuum. The residue was purified by column chromatography (heptane/ EtOAc) to give 2-(benzyloxy)-4-ethyl-6-methylpyridine-3-carbonitrile (Cpd BB, 1.42 g, 83%) as a colorless oil. To a -5 °C solution of 2-(benzyloxy)-4-ethyl-6-methylpyridine-3-carbonitrile (Cpd BB, 0.687 g, 2.72 mmol) in dichloromethane (9 mL) was added diisobutylalluminum hydride (3 mL of a 1M solution in DCM, 3 mmol). After 3 hours, the reaction mixture was quenched with 1M aqueous hydrochloric acid (3 mL). After stirring for 15 minutes, a 2M aqueous solution of potassium sodium tartrate (Rochelle's salt) (3 mL) was added. After stirring for 30 min., the resulting mixture was filtered through CELITE®. The To a solution of compound 3 (230 mg, 0.351 mmol) in dry DCM (5 mL) was added TFA (5 mL) dropwise at 0 o C. After the addition, the mixture was stirred at 25 o C for 18 hours. The reaction mixture became yellow. The pH of the mixture was adjusted to pH ~9 using sat. aq. NaHCO 3 and then the mixture was diluted with DCM (30 mL). The aqueous layer was extracted with DCM (3 x 30 mL) and the combined organic layers were washed with brine (30 mL), dried over Na 2 SO 4 and concentrated to give the crude product as a yellow oil. This material was dissolved in MeOH (30 mL) and solid K 2 CO 3 (200 mg, . The organics were extracted with EtOAc (3 x 30 mL) and the combined organic extract was washed with sat. aq. Na 2 CO 3 (4 x 30 mL), H 2 O (30 mL) and brine (2 x 30 mL). After drying over Na 2 SO 4 , concentration of the extract gave the crude product as a yellow gum. The crude product was purified by preparative TLC (silica gel, EtOAc: MeOH=15: 1, Rf ~0.3) to afford the product which was suspended in water, frozen and lyophilized for 18 hours to give compound 1 (85 mg, 48%) as a white solid. 
